ArticleVirus research2025
Isolation and characterization of a novel bacteriophage ST1749 and its effectiveness against Vibrio parahaemolyticus and Salmonella spp.
Article in Virus research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Isolation and characterization of a novel Schitoviridae phage VipHU7 that infects Vibrio parahaemolyticus.Archives of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacteriophages are extensively employed across various fields, including medicine, veterinary medicine, the food industry, agriculture, biotechnology, and pharmacy, owing to their numerous advantages. These advantages include rapid clearance of pathogens, self-propagation at the infection site, host specificity, potential for genetic modification, ease of isolation, stability, and low production costs. This study isolated a bacteriophage from shrimp pond wastewater in the Mekong Delta region. The bacteriophage was identified as a lytic bacteriophage belonging to the genus Bruyoghevirus, class Caudoviricetes, with the ability to effectively lyse three bacterial strains: V. parahaemolyticus, Salmonella enteritidis, and Salmonella typhimurium. Growth curve analysis revealed variations in the latency period and the number of phages produced during the life cycle across all three hosts. Bacteriophage Produced 117, 176, and 52 PFU/cell against V. parahaemolyticus, S. enteritidis, and S. typhimurium, respectively. Phage ST1749 demonstrated activity across a broad range of temperatures (-20 °C to 70 °C) and pH levels (2 to 10), with optimal stability observed at pH 5 to 7. Furthermore, phage ST1749 exhibited biofilm-degrading and lytic capabilities against the three bacterial strains studied. These findings suggest that phage ST1749 has the potential to serve as a biocontrol agent for treating infections caused by antibiotic-resistant bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.